| Similar Articles |
|---|
 |
The Motley Fool
February 9, 2011
Luke Timmerman |
Amgen Pushes Ahead With "Son of Dmab" for Treating Bones Is there more to Amgen than "Dmab"?   |
Reactive Reports
Issue 51
David Bradley |
Cannabinoids and Osteoporosis Researchers have discovered a regulatory mechanism involved in bone loss linked to a chemical receptor in our bodies with a previously unknown function, which could lead to a new treatment. |
Seasoned Cooking
July 2005
Michael Fick |
Dem Bones Unless we patients, our doctors, and the whole medical profession change our acts, our aging population, lazier lifestyles, and junk food diets will lead to half of Americans over the age of 50 having osteoporosis or being at high risk for it. |
Pharmaceutical Executive
October 1, 2008
Joanna Breitstein |
The D-Mab Men Amgen's salvation just may be denosumab. We sit down to talk with the head scientists driving the drug for the multi-billion dollar osteoporosis market |
BusinessWeek
June 21, 2004
Catherine Arnst |
Guard Your Bones Osteoporosis is one of the biggest health risks facing older women. What can be done to help prevent this disease? |
BusinessWeek
June 21, 2004
Carol Marie Cropper |
Osteoporosis: Men Suffer, Too Bone loss is a bigger threat than prostate cancer for men. |
American Family Physician
March 15, 2001
Jeannette E. South-Paul |
Osteoporosis: Part II. Nonpharmacologic and Pharmacologic Treatment Family physicians will frequently encounter patients with osteoporosis, a condition that is often asymptomatic until a fracture occurs... |
Nurse Practitioner
June 2009
Ivy M. Alexander |
Pharmacotherapeutic management of osteoporosis and osteopenia The estimated number of individuals with osteoporosis and osteopenia, the precursor to osteoporosis, continues to increase. |
BusinessWeek
June 13, 2005
Catherine Arnst |
Biotech, Finally The past 30 years of biological discoveries, insights into the human genome, and exotic chemical manipulation have unleashed a wave of biological drugs, many of them reengineered human proteins. |
BusinessWeek
August 13, 2009
Arlene Weintraub |
Amgen's Bone-Loss Drug Faces Marketing Hurdles Amgen is likely to receive FDA approval for denosumab, its new biologic bone-loss drug, but it may be a hard sell against cheaper generics. |
American Journal of Nursing
August 2011
Karen Roush |
Prevention and Treatment of Osteoporosis in Postmenopausal Women: A Review This article provides an overview of osteoporosis, describes current recommendations for its prevention and treatment, and discusses nursing implications. |
American Family Physician
March 1, 2004 |
Osteoporosis The definition, signs, and who's at risk of getting osteoporosis. |
BusinessWeek
January 14, 2010
Rob Waters |
Amgen: Strengthening Bones, Weakening Cancer? Regulators may soon approve an Amgen drug, denosumab, for osteoporosis, but the payoff could be in oncology. |
American Family Physician
March 1, 2001
Jeannette E. South-Paul |
Osteoporosis: Part I. Evaluation and Assessment Because osteoporosis is usually asymptomatic until a fracture occurs, family physicians must identify the appropriate timing and methods for screening those at risk... |
HHMI Bulletin
Nov 2010
Mitch Leslie |
Immune System Defects Can Cause Obsessive Behavior A shortage of certain immune cells might prompt obsessive-compulsive disorder. |
American Family Physician
May 15, 2002
Doron Schneider |
Diagnosis and Treatment of Paget's Disease of Bone Paget's disease of bone (also known as osteitis deformans) is a nonmalignant disease involving accelerated bone resorption followed by deposition of dense, chaotic, and ineffectively mineralized bone matrix... |
Food Processing
June 2013
Mark Anthony |
Boning Up on Nutrition: Food Manufacturers Take a Closer Look at Dietary Calcium With a $4 billion bone and joint health market, functional ingredient manufacturers look to dietary calcium and Vitamin D's capabilities to help restore cracks in bone health. |
Chemistry World
May 8, 2007
Lionel Milgrom |
Yearly Anti-Osteoporosis Jab Goes Straight to the Bone One injection of a new anti-osteoporosis drug a year can stop osteoporotic bone fractures in post-menopausal women, report researchers. The drug is already marketed by Novartis as Zometa (zoledronic acid) for use in several other disorders. |
Pharmaceutical Executive
July 30, 2007 |
Tomorrow's Drugs A look at the seven top therapies and technologies vying to deliver the next generation of drugs. |
The Motley Fool
May 13, 2005
Karl Thiel |
Boning Up on New Drugs Are new osteoporosis therapies compelling investments, or is the field too crowded? |
American Family Physician
April 1, 2003
Campion & Maricic |
Osteoporosis in Men Osteoporosis in men is now recognized as an increasingly important public health issue. Increased awareness by physicians of risk factors for male osteoporosis -- and early diagnosis and treatment -- are needed to decrease the morbidity and mortality resulting from osteoporotic fractures. |
Popular Mechanics
January 28, 2010
Cassie Rodenberg |
Next-Gen Transplant Techniques Can Stop Organ Rejection About 77 organ transplants are performed each day in the U.S., and more than 101,000 people are on a wait list for body parts such as hearts, skin and veins, according to the Mayo Clinic. |
American Family Physician
August 15, 2002 |
Vertebroplasty for Spine Fracture Pain How are spinal fractures treated?... What is percutaneous vertebroplasty?... What is the recovery like?... Is the procedure safe?... How do I know if vertebroplasty is right for me?... How successful is vertebroplasty?... etc. |
Food Processing
June 2011
Dave Fusaro |
How Can Food Processors Help Consumers' Aching and Aging Bones? Beyond vitamin D and phosphate, new ingredients help support calcium. |
BusinessWeek
May 24, 2004
Arlene Weintraub |
Repairing The Engines Of Life Can research into stem cells and other advanced techniques heal ailing hearts and brains? U.S. labs are hamstrung by the federal government. |
The Motley Fool
February 9, 2010
Brian Orelli |
Bone Up On This Potential Blockbuster Amgen's denosumab passes another test on its way to potential blockbuster status. |
Science News
November 9, 2002
Janet Raloff |
Young Women Don't Bone Up on Soy If soy's good for older women, it should similarly benefit women in their 20s -- fortifying their bodies' structural scaffolding during peak bone-building years. But recent research finds zero benefit for younger women. |
Scientific American
January 2009
Charles Q. Choi |
Do White Blood Cells Make Cancer Deadly? The ability to spread underlies the killing power of cancer. The process occurs, John Pawelek thinks, when tumor cells fuse with white blood cells -- an idea that, if right, could yield new therapies |
Nutra Solutions
July 23, 2007
Ginny Banks |
A New Look at Bone Health Although vitamin D and calcium are the mainstay ingredients for osteoporosis prevention, studies show that vitamin K2, phosphorous, magnesium, prebiotics and soy can also play a role. |
The Motley Fool
June 6, 2011
Luke Timmerman |
Exelixis Zeroes In on Lead Drug, Sees Activity in the Bones of Prostate Cancer Patients Is Exelixis' risky bet about to pay off? |
Chemistry World
February 13, 2013
Michael Parkin |
Bone-repairing nanoparticles laced with DNA A bone-repairing nanoparticle paste has been developed that promises faster repair of fractures and breakages. DNA containing two growth-factor genes is encapsulated inside synthetic calcium-phosphate nanoparticles. |
The Motley Fool
November 19, 2010
Brian Orelli |
One Drug, Two Names, Two Wildly Different Prospects Amgen double speaks for increased sales. |
The Motley Fool
November 9, 2004
Charly Travers |
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. |
The Motley Fool
December 14, 2010
Brian Orelli |
An Ounce of Prevention, a Pound of Blockbuster Sales Amgen's Xgeva recently gained Food and Drug Administration approval to treat cancer patients that have bone metastasis. |
IEEE Spectrum
October 2007
Morgen E. Peck |
Imperceptible Vibrations Slow Weight Gain New research by engineers and scientists show how low-level mechanical signals inhibit fat-cell production in mice. |
Chemistry World
January 24, 2008
Jonathan Edwards |
Trio of Papers Cast Doubts on Osteoporosis Treatment Calcium isn't as effective or safe as previously thought, and millions of people may be taking unnecessary preventative treatments. |
The Motley Fool
December 10, 2010
Brian Orelli |
Something Is Better Than Nothing, I Guess Novartis' Zometa fails a critical clinical trial. |
BusinessWeek
December 6, 2004
Catherine Arnst |
Cord Blood To The Rescue A study in the Nov. 25 issue of The New England Journal of Medicine confirms that stem cells in blood extracted from the umbilical cords of newborns can help leukemia patients |
The Motley Fool
April 19, 2004
Charly Travers |
4 Promising Biotech IPOs Several recently gone-public biotechs boast surprisingly interesting drug pipelines. From drugs for hepatitis to hopeful cancer treatments, watch out for these four biotech debutantes. If trials go smoothly, they may be the next up-and-coming stocks in the industry. |
American Family Physician
April 1, 2002
Richard Brunader |
Radiologic Bone Assessment in the Evaluation of Osteoporosis Because osteoporosis affects a large number of patients with potentially significant morbidity and mortality, it is important to identify patients at risk so that physicians can effectively intervene... |
Nurse Practitioner
June 2012
Jane E. Corrarino |
Stress fractures in runners Many runners in the United States are at risk for stress-related injuries, which are largely preventable. This article explores risks, pathophysiology, diagnostic considerations, and rehabilitation. |
Chemistry World
February 4, 2008
Richard Van Noorden |
Green Chemistry Aids Bone Repair A biodegradable polymer made with green solvents can mend broken thigh bones in mice, researchers have shown. |
Chemistry World
April 2007
Jon Evans |
Better, Stronger, Faster In the 1970s, the idea of building a bionic man was merely fantastical. Now we have bionic eyes and limbs, and chemists are creating artificial bodily tissues to rival nature's own. |
American Family Physician
March 15, 2002 |
Osteosarcoma What is osteosarcoma?... Who gets osteosarcoma?... What are some signs of osteosarcoma?... What tests will the doctor use to tell if my child has osteosarcoma?... How is osteosarcoma treated?... What can we expect after treatment?... |
The Motley Fool
December 17, 2007
Jack Uldrich |
Innovations and Opportunities The latest scientific news is about fighting aging, heart disease, and cancer. |
Pharmaceutical Executive
December 1, 2005
Ron Feemster |
The PharmExec 2005 Pipeline Report Dry? Not quite. Instead of 1990s-style blockbusters, pharma's new molecules are niche drugs, cancer treatments and -- at last -- innovative mechanisms for troublesome targets: Acomplia [rimonabant] by Sanofi-Aventis... AMG 162 [denosumab] by Amgen... etc. |
American Family Physician
March 1, 2001 |
What You Should Know About Osteoporosis What is osteoporosis?... Who gets osteoporosis?... What are the effects of osteoporosis?... How does my doctor know I have osteoporosis?... How is osteoporosis treated?... How is osteoporosis prevented?... etc. |
Chemistry World
October 15, 2007
Jonathan Edwards |
Bones Heal Faster with Nanocrystals A nanocrystalline cement could help bone grafts to heal more quickly, Chinese scientists have claimed. |
The Motley Fool
July 8, 2009
Brian Orelli |
Amgen Closes In on a Home Run Amgen already had a ball flying high above the outfield in its osteoporosis treatment, denosumab, but yesterday's clinical trial results were the wind that could push it out of the park. |
American Family Physician
April 15, 2004
Bazaldua & Bruder |
STEPS Drug Update Teriparatide (Forteo) for Osteoporosis |
